Company: DRTSW
Filing Date: 2025-03-12
Form Type: 20-F
Source: 0001213900-25-023187
Chunk: 58

Company: Alpha Tau Medical Ltd.
Filing Date: 2025-03-12
Form: 20-F
Item: Item 3
Chunk 58
---
20 years from its earliest
U. S. non-provisional filing date. Various extensions may be available, but the life of a patent, and the protection it affords, is limited.
Even if patents covering our products are obtained, once the patent life has expired for a product, we may be open to competition. Given
the amount of time required for the development, testing and regulatory review of new products, patents protecting such products might
expire before or shortly after such products are commercialized. As a result, our patent portfolio may not provide us with sufficient
rights to exclude others from commercializing products similar or identical to ours for a meaningful amount of time, or at all.

If we are unable to protect the confidentiality
of our trade secrets, our business and competitive position would be harmed.

In addition to the protection
afforded by patents, we seek to rely on trade secret protection and confidentiality agreements to protect proprietary know-how that is
not patentable, processes for which patents are difficult to enforce and any other elements of our product discovery and development processes
that involve proprietary know-how, information, or technology that is not covered by our patents. Elements of our products, including
processes for their preparation and manufacture, may involve proprietary know-how, information, or technology that is not covered by patents,
and thus for these aspects we may consider trade secrets and know-how to be our primary intellectual property. Any disclosure, either
intentional or unintentional, by our employees or third-party consultants and vendors that we engage to perform research, clinical trials
or manufacturing activities, or misappropriation by third parties (such as through a cybersecurity breach) of our trade secrets or proprietary
information could enable competitors to duplicate or surpass our technological achievements, thus eroding our competitive position in
our market. Because we expect to rely on third parties in the development and manufacture of our products, we must, at times, share trade
secrets with them. Our reliance on third parties requires us to share our trade secrets, which increases the possibility that a competitor
will discover them or that our trade secrets will be misappropriated or disclosed.

Trade secrets and know-how
can be difficult to protect. We require all of our employees to enter into written employment agreements containing provisions of confidentiality
and obligations to assign any inventions generated in the course of their employment to us. Further, we enter into non-disclosure and
confidentiality agreements with our corporate collaborators, outside scientific collaborators, contract research organizations, contract
manufacturers